EPCAM and neoplasm: In conclusion, our study shows that NAG-1/GDF15, via its full-length pro-NAG-1/GDF15 form, functions intracellularly as a tumor suppressor by inhibiting the oncogenic protein EpCAM, which in turn reduces β-catenin and NF-κB signaling.